Federal contract award
75N91022C00012
SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R699 — Other Administrative Support Services |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $10.2M |
| Current contract value | $10.2M |
| Potential contract value / ceiling | $12.5M |
| Start date | Sep 1, 2022 |
| Current end date | Aug 31, 2027 |
| Potential end date | Aug 31, 2027 |
| Latest award activity | Aug 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 21, 2026 | P00005 | $2.3M | EO 14398 MANAGEMENT AND DISTRIBUTION OF AGENTS USED IN THE MAJORITY OF NCI SPONSORED TREATMENT TRIALS, AS WELL AS AGENT DISTRIBUTION SUPPORT FOR SELECT DIVISION OF CANCER PREVENTION (DCP) AND NON-NCI SPONSORED TREATMENT TRIALS |
| Aug 27, 2025 | P00004 | $2.2M | MANAGEMENT AND DISTRIBUTION OF AGENTS USED IN THE MAJORITY OF NCI SPONSORED TREATMENT TRIALS, AS WELL AS AGENT DISTRIBUTION SUPPORT FOR SELECT DIVISION OF CANCER PREVENTION (DCP) AND NON-NCI SPONSORED TREATMENT TRIALS |
| May 13, 2025 | P00003 | $0 | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) |
| Aug 6, 2024 | P00002 | $2.0M | SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) |
| Aug 21, 2023 | P00001 | $1.9M | SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) |
| Jun 29, 2022 | 0 | $1.9M | SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) |
Estimated positioning window
Oct 25, 2026 – Feb 28, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-08-31 (310 days from calculation)
- +35 points
- 10 historical awards in this buyer and category group
- +15 points
- 6 recorded award transactions
- +10 points
- Latest award action: 2026-08-21
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Mesfin Alemayehu | Contact | mesfin.alemayehu@nih.gov 240-276-7995 | Source | Aug 24, 2021 |
| Pooja Rathore | Contact | pooja.rathore@nih.gov 240-276-7325 | Source | Aug 24, 2021 |
| Mesfin Alemayehu | Contact | mesfin.alemayehu@nih.gov 240-276-7995 | Source | Aug 9, 2021 |
| Pooja Rathore | Contact | pooja.rathore@nih.gov 240-276-7325 | Source | Aug 9, 2021 |
| Mesfin Alemayehu | Contact | mesfin.alemayehu@nih.gov 240-276-7995 | Source | Jul 22, 2021 |
| Pooja Rathore | Contact | pooja.rathore@nih.gov 240-276-7325 | Source | Jul 22, 2021 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.